|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Product | |||||
| Contract and Other | |||||
| Total revenues | |||||
| Cost of revenues | |||||
| Gross profit | |||||
| Operating expenses | |||||
| Selling, general and administrative | |||||
| Goodwill impairment | |||||
| Research and development | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other expenses | |||||
| Interest income | |||||
| Interest expense | |||||
| Change in fair value of Term Loans and warrants | |||||
| Other | |||||
| Other expenses, net | |||||
| Loss before income taxes | |||||
| Income tax expense (benefit) | |||||
| Net loss | |||||
| Net loss per common share - basic (in dollars per share) | |||||
| Net loss per common share - diluted (in dollars per share) | |||||
| Weighted average common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...